- ¥263bn
- ¥274bn
- ¥301bn
- 89
- 60
- 75
- 90
Annual balance sheet for Meidensha, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 14,307 | 14,070 | 14,917 | 18,984 | 30,679 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 94,038 | 100,618 | 107,930 | 115,400 | 112,118 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 157,183 | 171,294 | 187,751 | 208,503 | 217,116 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 75,623 | 74,947 | 75,788 | 75,363 | 75,061 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 279,059 | 290,899 | 307,390 | 334,787 | 341,347 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 103,824 | 104,406 | 118,307 | 124,242 | 118,069 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 182,524 | 188,933 | 199,492 | 208,380 | 202,570 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 96,535 | 101,966 | 107,898 | 126,407 | 138,777 |
| Total Liabilities & Shareholders' Equity | 279,059 | 290,899 | 307,390 | 334,787 | 341,347 |
| Total Common Shares Outstanding |